ReviewInternational journal of stem cells2023

Establishing Rationale for the Clinical Development of Cell Therapy Products: Consensus between Risk and Benefit.

Seunghoon Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.